![Katja Rosenkranz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Katja Rosenkranz
Direktör/Styrelseledamot på
Dualyx NV
Profil
Katja Rosenkranz is currently the Director at dualyx NV since 2020 and a Partner at V-Bio Ventures BV since 2016.
Previously, she worked as the Director-Executive Board at Clearstream Banking AG from 2009 to 2012.
She also held positions as Director at AgomAb Therapeutics NV and COO, CFO & Head-Administration at Advitos GmbH from 2009 to 2012.
Aktiva positioner av Katja Rosenkranz
| Företag | Position | Start |
|---|---|---|
V-Bio Ventures BV
 V-Bio Ventures BV Investment ManagersFinance V-Bio Ventures invests in companies located in Europe and beyond. The firm focuses on sectors such as therapeutics, including both drug discovery and drug development. It participates in early stage capital requirements. | Privat kapitalinvesterare | 2016-01-01 |
Dualyx NV
 Dualyx NV Miscellaneous Commercial ServicesCommercial Services Develops differentiated biologicals for autoimmune diseases | Direktör/Styrelseledamot | 2020-05-31 |
Tidigare kända positioner av Katja Rosenkranz
| Företag | Position | Slut |
|---|---|---|
Clearstream Banking AG
 Clearstream Banking AG Regional BanksFinance Provides commercial banking services | Företagsledare/Principal | 2012-03-31 |
| AGOMAB THERAPEUTICS NV | Direktör/Styrelseledamot | - |
Advitos GmbH
 Advitos GmbH Medical SpecialtiesHealth Technology Develops and commercializes liver support therapy devices | Finansdirektör/CFO | 2012-06-14 |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
11
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Clearstream Banking AG
Clearstream Banking AG Regional BanksFinance Provides commercial banking services | Finance |
Advitos GmbH
Advitos GmbH Medical SpecialtiesHealth Technology Develops and commercializes liver support therapy devices | Health Technology |
V-Bio Ventures BV
V-Bio Ventures BV Investment ManagersFinance V-Bio Ventures invests in companies located in Europe and beyond. The firm focuses on sectors such as therapeutics, including both drug discovery and drug development. It participates in early stage capital requirements. | Finance |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues | Health Technology |
Dualyx NV
Dualyx NV Miscellaneous Commercial ServicesCommercial Services Develops differentiated biologicals for autoimmune diseases | Commercial Services |
